Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2331293 | 0.91 | NPSR1 (0.38) | NPSR1ALDH1A1LTA4HL3MBTL1KCNH2 | |
| SCHEMBL2347611 | 0.83 | MEN1 (0.41) | ALDH1A1LTA4HTP53MEN1KMT2A | |
| SCHEMBL2325371 | 0.79 | LTA4H (0.44) | NPSR1ALDH1A1LTA4HL3MBTL1MEN1 | |
| SCHEMBL2325321 | 0.78 | LTA4H (0.44) | NPSR1ALDH1A1LTA4HL3MBTL1KCNH2 | |
| SCHEMBL2473222 | 0.78 | TRPA1 (0.33) | ALDH1A1L3MBTL1 | |
| SCHEMBL2347755 | 0.77 | LTA4H (0.43) | NPSR1ALDH1A1LTA4HL3MBTL1KCNH2 | |
| SCHEMBL2344253 | 0.77 | LTA4H (0.43) | NPSR1ALDH1A1LTA4HL3MBTL1KCNH2 | |
| SCHEMBL2348524 | 0.77 | LTA4H (0.43) | NPSR1ALDH1A1LTA4HL3MBTL1KCNH2 | |
| SCHEMBL2325240 | 0.77 | LTA4H (0.43) | NPSR1ALDH1A1LTA4HL3MBTL1KCNH2 | |
| SCHEMBL2339079 | 0.77 | LTA4H (0.43) | NPSR1ALDH1A1LTA4HL3MBTL1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1535896-B1 | PROCESS FOR PRODUCING CARBONIC ESTER | ASAHI KASEI CHEMICALS CORP (JP) | 2015-10-07 | — | — | EP | disclosed |
| EP-1460056-B1 | METHOD FOR PRODUCING A CARBONIC ESTER | ASAHI KASEI CHEMICALS CORP (JP) | 2011-10-05 | — | — | EP | disclosed |
| EP-1640357-B1 | METHOD FOR PRODUCING AROMATIC CARBONATE | ASAHI KASEI CHEMICALS CORP (JP) | 2011-08-31 | — | — | EP | disclosed |
| US-7652122-B2 | Method for producing an aromatic carbonate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-01-26 | — | — | US | disclosed |
| US-7446218-B2 | Process for producing carbonic ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2008-11-04 | — | — | US | disclosed |
| US-7435842-B2 | Process for producing carbonic ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2008-10-14 | — | — | US | disclosed |
| US-20070055042-A1 | Method for producing an aromatic carbonate | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2007-03-08 | — | — | US | disclosed |
| EP-1640357-A1 | METHOD FOR PRODUCING AROMATIC CARBONATE | Asahi Kasei Chemicals Corporation (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-20050240045-A1 | Process for producing carbonic ester | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2005-10-27 | — | — | US | disclosed |
| EP-1535896-A1 | PROCESS FOR PRODUCING CARBONIC ESTER | Asahi Kasei Chemicals Corporation (JP) | 2005-06-01 | — | — | EP | disclosed |
| US-20050080274-A1 | Process for producing carbonic ester | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2005-04-14 | — | — | US | disclosed |
| EP-1460056-A1 | PROCESS FOR PRODUCING CARBONIC ESTER | Asahi Kasei Chemicals Corporation (JP) | 2004-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080274-A1 | Process for producing carbonic ester | CYP2E1, ADH1A, ALKBH3 | NPSR1 4658/4885ALDH1A1 264/4885LTA4H 1561/4885 |
| US-20050240045-A1 | Process for producing carbonic ester | ALKBH3, CYP4A11, CYP2E1 | NPSR1 4316/4885ALDH1A1 471/4885LTA4H 1550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.